Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · IEX Real-Time Price · USD
5.16
-0.10 (-1.90%)
At close: Jul 19, 2024, 4:00 PM
5.21
+0.05 (0.97%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Prelude Therapeutics Market Cap
Prelude Therapeutics has a market cap or net worth of $283.44 million as of July 22, 2024. Its market cap has increased by 34.97% in one year.
Market Cap
283.44M
Enterprise Value
95.11M
1-Year Change
34.97%
Ranking
Category
Stock Price
$5.16
Market Cap Chart
Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $283.44M, a decrease of -64.86%. That is a compound annual growth rate of -23.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 283.40M | 21.06% |
| Dec 29, 2023 | 234.10M | -19.02% |
| Dec 30, 2022 | 289.10M | -50.82% |
| Dec 31, 2021 | 587.80M | -81.20% |
| Dec 31, 2020 | 3.13B | 287.66% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alimera Sciences | 291.80M |
| Aquestive Therapeutics | 291.32M |
| AngioDynamics | 287.59M |
| Orchestra BioMed Holdings | 287.38M |
| MeiraGTx Holdings | 284.24M |
| Akebia Therapeutics | 282.95M |
| Omeros | 282.77M |
| Accolade | 276.03M |